These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18154029)

  • 21. [Comparison of fibrinogen synthesis and secretion between novel variant fibrinogen, nagakute (gamma305Thr --> Ala), and other variants located in gamma305-308 residues].
    Kobayashi T; Takezawa Y; Terasawa F; Okumura N
    Rinsho Byori; 2012 Sep; 60(9):831-8. PubMed ID: 23157111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rotational thromboelastography for monitoring of fibrinogen concentrate therapy in fibrinogen deficiency.
    Kalina U; Stöhr HA; Bickhard H; Knaub S; Siboni SM; Mannucci PM; Peyvandi F
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):777-83. PubMed ID: 19002044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coexisting congenital dysfibrinogenemia with a novel mutation in fibrinogen γ chain (γ322 Phe→Ile, Fibrinogen Beijing) and haemophilia B in a family.
    Hua B; Li K; Lee A; Poon MC; Zhao Y
    Haemophilia; 2015 Nov; 21(6):846-51. PubMed ID: 25982359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
    Hunault-Berger M; Chevallier P; Delain M; Bulabois CE; Bologna S; Bernard M; Lafon I; Cornillon J; Maakaroun A; Tizon A; Padrazzi B; Ifrah N; Gruel Y;
    Haematologica; 2008 Oct; 93(10):1488-94. PubMed ID: 18728028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrinogen Poissy II (gammaN361K): a novel dysfibrinogenemia associated with defective polymerization and peptide B release.
    Mathonnet F; Guillon L; Detruit H; Mazmanian GM; Dreyfus M; Alvarez JC; Giudicelli Y; de Mazancourt P
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):293-8. PubMed ID: 12695754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel heterozygous dysfibrinogenemia, Sumida (AαC472S), showed markedly impaired lateral aggregation of protofibrils and mildly lower functional fibrinogen levels.
    Ikeda M; Arai S; Mukai S; Takezawa Y; Terasawa F; Okumura N
    Thromb Res; 2015 Apr; 135(4):710-7. PubMed ID: 25613923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel fibrinogen variant--Liberec: dysfibrinogenaemia associated with gamma Tyr262Cys substitution.
    Kotlín R; Sobotková A; Suttnar J; Salaj P; Walterová L; Riedel T; Reicheltová Z; Dyr JE
    Eur J Haematol; 2008 Aug; 81(2):123-9. PubMed ID: 18485115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of Fibrinogen Determination Methods in Differential Diagnosis of Hypofibrinogenemia and Dysfibrinogenemia.
    Skornova I; Simurda T; Stasko J; Horvath D; Zolkova J; Holly P; Brunclikova M; Samos M; Bolek T; Schnierer M; Slavik L; Kubisz P
    Clin Lab; 2021 Apr; 67(4):. PubMed ID: 33865248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The amplitude of coagulation curves from thrombin time tests allows dysfibrinogenemia caused by the common mutation FGG-Arg301 to be distinguished from hypofibrinogenemia.
    Jacquemin M; Vanlinthout I; Van Horenbeeck I; Debasse M; Toelen J; Schoeters J; Lavend'homme R; Freson K; Peerlinck K
    Int J Lab Hematol; 2017 Jun; 39(3):301-307. PubMed ID: 28318107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Congenital hypofibrinogenemia and recurrent placental abruption.
    Ness PM; Budzynski AZ; Olexa SA; Rodvien R
    Obstet Gynecol; 1983 Apr; 61(4):519-23. PubMed ID: 6828283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Misdiagnosis of a patient with congenital dysfibrinogenemia: A case report and literature review.
    Chen X; Yan J; Xiang L; Lin F
    J Clin Lab Anal; 2022 Sep; 36(9):e24624. PubMed ID: 35949040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Congenital afibrinogenemia complicated by spontaneous cerebral hemorrhages: a case report].
    Tovone XG; Rasamoelisoa JM; Rakotomalala S; Rabesiaka F; Rakotoarimanana DR; Ramialiharisoa A
    Arch Inst Pasteur Madagascar; 1999; 65(1-2):117-9. PubMed ID: 12478976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A dysfibrinogenemia leading to resistance to bovine thrombin.
    Depoorter M; Eeckhoudt S
    Acta Clin Belg; 2014 Dec; 69(6):451-3. PubMed ID: 25103594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Genetic Analysis of A Case of Congenital Dysfibrinogenemia Caused by Arg16His Mutation in Exon 2 of FGA].
    Zhang YL; Liu SY; Zhang ZL; Tao XY; Peng XX; Kong YY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1514-1517. PubMed ID: 29070135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rare inherited disorders of fibrinogen.
    Acharya SS; Dimichele DM
    Haemophilia; 2008 Nov; 14(6):1151-8. PubMed ID: 19141154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pedigree Analysis and Diagnosis of Congenital Dysfibrinogenemia: A Case Report].
    Luo J; Duan SR; Wang H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):171-174. PubMed ID: 35048620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Congenital hypofibrinogenemia: characterization of two missense mutations affecting fibrinogen assembly and secretion.
    Platè M; Asselta R; Spena S; Spreafico M; Fagoonee S; Peyvandi F; Tenchini ML; Duga S
    Blood Cells Mol Dis; 2008; 41(3):292-7. PubMed ID: 18676163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of an Inherited Dysfibrinogenemia Pedigree Associated with a Heterozygous Mutation in the FGA Gene.
    Li S; Wang M; Li X; Xu Q; Liu S; Luo S; Chen Y
    Hamostaseologie; 2020 Dec; 40(5):642-648. PubMed ID: 33374030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet and fibrinogen survival with 75Se selenomethionine in acute infectious hepatitis.
    Musumeci S; D'Agata A; Panebianco MG; Volti SL
    Thromb Diath Haemorrh; 1975 Jun; 33(3):493-500. PubMed ID: 1154308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined use of Clauss and prothrombin time-derived methods for determining fibrinogen concentrations: Screening for congenital dysfibrinogenemia.
    Xiang L; Luo M; Yan J; Liao L; Zhou W; Deng X; Deng D; Cheng P; Lin F
    J Clin Lab Anal; 2018 May; 32(4):e22322. PubMed ID: 28922493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.